pioglitazone has been researched along with Allergic Neuritis, Experimental in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hurbungs, A; Li, J; Ramkalawan, H; Tian, FF; Wang, YZ; Xiao, B; Yang, H; Yang, YF; Zhang, W; Zhou, WB | 1 |
1 other study(ies) available for pioglitazone and Allergic Neuritis, Experimental
| Article | Year |
|---|---|
Pioglitazone, PPARĪ³ agonist, attenuates experimental autoimmune neuritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Interferon-gamma; Interleukin-4; Male; Neuritis, Autoimmune, Experimental; NF-kappa B; Pioglitazone; PPAR gamma; Random Allocation; Rats; Rats, Inbred Lew; Signal Transduction; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2012 |